tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

UPB Stock Latest News

Positive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment
RatingsPositive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment
9d ago
UPB
Promising Outlook for Upstream Bio, Inc. as Verekitug Advances in Inflammatory Conditions
PremiumRatings
Promising Outlook for Upstream Bio, Inc. as Verekitug Advances in Inflammatory Conditions
9d ago
UPB
3 Best Stocks to Buy Now, 7/23/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/23/2025, According to Top Analysts
14d ago
EXE
SUN
Promising Outlook for Upstream Bio: Buy Rating Backed by Innovative CRSwNP Treatment and Strategic Leadership
PremiumRatings
Promising Outlook for Upstream Bio: Buy Rating Backed by Innovative CRSwNP Treatment and Strategic Leadership
14d ago
UPB
Upstream Bio management to meet with Piper Sandler
PremiumThe Fly
Upstream Bio management to meet with Piper Sandler
21d ago
UPB
Upstream Bio doses first patient in Phase 2 trial of verekitug in COPD
PremiumThe FlyUpstream Bio doses first patient in Phase 2 trial of verekitug in COPD
28d ago
UPB
Six new option listings and two option delistings on July 1st
Premium
The Fly
Six new option listings and two option delistings on July 1st
1M ago
FTV
RGC
Upstream Bio, Inc.: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
Premium
Ratings
Upstream Bio, Inc.: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
2M ago
UPB
Upstream Bio, Inc.’s Verekitug: A Promising Contender in the TSLPR Antibody Space
PremiumRatings
Upstream Bio, Inc.’s Verekitug: A Promising Contender in the TSLPR Antibody Space
2M ago
UPB
Upstream Bio announces presentation of data on verekitug’s TSLP receptor
PremiumThe Fly
Upstream Bio announces presentation of data on verekitug’s TSLP receptor
2M ago
UPB
Upstream Bio Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Upstream Bio Holds 2025 Annual Stockholders Meeting
2M ago
8K
UPB
Upstream Bio appoints Price as CTO
PremiumThe Fly
Upstream Bio appoints Price as CTO
3M ago
UPB
Upstream Bio Advances Verekitug in Clinical Trials
PremiumCompany AnnouncementsUpstream Bio Advances Verekitug in Clinical Trials
3M ago
UPB
Upstream Bio, Inc.: Strong Buy Rating Driven by Promising Drug Progress and Solid Financial Position
Premium
Ratings
Upstream Bio, Inc.: Strong Buy Rating Driven by Promising Drug Progress and Solid Financial Position
3M ago
UPB
Upstream Bio reports Q1 revenue $566k, consensus $326.25k
Premium
The Fly
Upstream Bio reports Q1 revenue $566k, consensus $326.25k
3M ago
UPB
Upstream Bio, Inc.: Promising Outlook with Strategic Positioning and Strong Trial Execution
PremiumRatings
Upstream Bio, Inc.: Promising Outlook with Strategic Positioning and Strong Trial Execution
5M ago
UPB
Upstream Bio’s Financial Results and Strategic Progress
PremiumCompany Announcements
Upstream Bio’s Financial Results and Strategic Progress
5M ago
UPB
Promising Developments and Strong Financial Position Drive Buy Rating for Upstream Bio, Inc.
PremiumRatings
Promising Developments and Strong Financial Position Drive Buy Rating for Upstream Bio, Inc.
5M ago
UPB
Buy Rating for Upstream Bio: Promising Clinical Progress and Unique Drug Candidate Potential
PremiumRatings
Buy Rating for Upstream Bio: Promising Clinical Progress and Unique Drug Candidate Potential
5M ago
UPB
Upstream Bio reports Q4 revenue $613k, consensus $384.75k
PremiumThe FlyUpstream Bio reports Q4 revenue $613k, consensus $384.75k
5M ago
UPB
Upstream Bio appoints Amrbose as General Counsel
Premium
The Fly
Upstream Bio appoints Amrbose as General Counsel
8M ago
UPB
Upstream Bio to be added to Russell 2000 Index
Premium
The Fly
Upstream Bio to be added to Russell 2000 Index
8M ago
UPB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >